Prolonged glucosuria and relapse of diabetic ketoacidosis related to SGLT2-inhibitor therapy

11Citations
Citations of this article
27Readers
Mendeley users who have this article in their library.

Abstract

SGLT2 inhibitors (SGLT2i) are glucose-lowering medications which increase the renal threshold for glucose reabsorption and promote glucosuria. Treatment with these agents raises serum ketone levels, and cases of diabetic ketoacidosis (DKA) during therapy have been reported. The duration of glucosuria and inpatient course of SGLT2i-related DKA, however, is not well-characterized. We report 11 inpatient cases of SGLT2i-related DKA, including a subset of patients who experienced prolonged glucosuria and relapse of DKA during their hospitalization.

Cite

CITATION STYLE

APA

Westcott, G. P., Segal, A. R., Mitri, J., & Brown, F. M. (2020). Prolonged glucosuria and relapse of diabetic ketoacidosis related to SGLT2-inhibitor therapy. Endocrinology, Diabetes and Metabolism, 3(2). https://doi.org/10.1002/edm2.117

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free